Stockscreener 앱 받기
0.779
0.52%
0.004
시장 영업 전:
.78
0.001
+0.13%
AEON Biopharma Inc. 주식(AEON)의 최신 뉴스
why aeon biopharma inc. stock attracts strong analyst attentionSmart Growth Low Risk Picks - Newser
what makes aeon biopharma inc. stock price move sharplyROI Focused Stock Calls - Newser
Why AEON Biopharma Inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser
What makes AEON Biopharma Inc. stock price move sharplyFree Access to Investment Community - Newser
How AEON Biopharma Inc. stock performs during market volatilitySmart Return Focused Trading - Newser
AEON Biopharma (NASDAQ:AEON) Trading Down 10.2% – Should You Sell? - Defense World
AEON Biopharma Holds Annual Stockholders Meeting - TipRanks
AEON Biopharma, Inc. (NASDAQ:AEON) Short Interest Update - Defense World
AEON Biopharma Soars 13.67% on CEO Appointment, Talent Grants - AInvest
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - The Manila Times
Aeon Biopharma Reports Positive Q1 2025 Earnings - TipRanks
AEON Biopharma Releases New Corporate Presentation - TipRanks
AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025 - The Manila Times
AEON Biopharma to Present Corporate Overview at Aegis Capital Corp. 2025 Virtual Conference - Nasdaq
AEON Biopharma Unveils Next-Gen Botulinum Toxin Therapies: CEO Details Multi-Indication Pipeline - Stock Titan
AEON Biopharma Advances Biosimilar Product Development and Appoints New CEO - Nasdaq
AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
New AEON CEO Targets $3.3B Botox Market with FDA-Ready Biosimilar Development Plan - Stock Titan
AEON Biopharma (AEON) Projected to Post Quarterly Earnings on Tuesday - Defense World
Closing Bell Recap: AEON Biopharma Inc (AEON) Ends at 0.75, Reflecting a -11.76 Downturn - DWinneX
AEON Biopharma Inc (AMEX: AEON) Stock: Investors Need To Know This - Stocksregister
Is AEON Biopharma Inc’s (AMEX:AEON) Stock On The Decline? - Stocksregister
AEON Biopharma gets NYSE American nod for compliance plan - Investing.com Australia
AEON Biopharma gets NYSE American nod for compliance plan By Investing.com - Investing.com Canada
AEON Biopharma Says NYSE American Accepts Plan to Regain Compliance - marketscreener.com
AEON Biopharma Receives Acceptance from NYSE American to Regain Compliance with Listing Standards - Nasdaq
AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance - The Manila Times
NYSE American Grants AEON Biopharma 2-Year Lifeline to Meet Listing Requirements - Stock Titan
AEON Biopharma’s Fight to Stay Listed: A High-Stakes Gamble? - AInvest
What was AEON Biopharma Inc (AEON)’s performance in the last session? - uspostnews.com
Analyzing the Impact of Earnings Reports on AEON Biopharma Inc Inc. (AEON) Price Performance - investchronicle.com
Who’s Hired? Botox Biosimilar Developer Aeon Takes CEO From Rival Revance - insights.citeline.com
AEON Biopharma, Inc. Announces Executive Changes, Effective as of April 4, 2025 - marketscreener.com
AEON Biopharma announces CEO appointment - MSN
AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer - The Manila Times
AEON Biopharma names Rob Bancroft as new CEO By Investing.com - Investing.com South Africa
Aeon Biopharma Names Robert Bancroft CEO - marketscreener.com
AEON Biopharma Appoints New CEO Robert Bancroft - TipRanks
Aeon Biopharma (AEON) Appoints Rob Bancroft as New CEO | AEON Stock News - GuruFocus
AEON Biopharma Appoints Rob Bancroft as CEO - MarketWatch
AEON Biopharma names Rob Bancroft as new CEO - Investing.com
AEON Biopharma (NASDAQ:AEON) Trading 2.5% Higher – Time to Buy? - Defense World
AEON Biopharma announces new interim CEO and CFO By Investing.com - Investing.com Australia
0.64%
0.37%
자본화:
|
볼륨(24시간):